Enzolytics Inc. announced the appointment, by the Board of Directors of the Company, on October 20 of Charles Cotropia to the position of CEO of the company. Charles S. Cotropia is co-founder and CEO of BioClonetics Immunotherapeutics Inc. Prior to his current position at BioClonetics, Mr. Cotropia served as a partner and senior counsel at Sidley Austin LLP in its Dallas office. He has over 45 years of litigation experience having handled cases in the areas of patents, trademarks, trade dress, unfair competition and copyrights.